Storgard相关文献与解析，生知库 | 链接生命科学的每一步

Dermatologic Adverse Events Associated With Chimeric Antigen Receptor T-Cell Therapy: A Pharmacovigilance Analysis of the FDA Reporting System

嵌合抗原受体T细胞疗法相关皮肤不良事件：FDA报告系统的药物警戒分析

期刊:Transplantation and Cellular Therapy

影响因子:4.4

doi:10.1016/j.jtct.2024.06.024

Storgard, Ryan; Dusza, Stephen; Shouval, Roni; Scordo, Michael; Markova, Alina

Platelet-Coated Circulating Tumor Cells Are a Predictive Biomarker in Patients with Metastatic Castrate-Resistant Prostate Cancer

血小板包被的循环肿瘤细胞是转移性去势抵抗性前列腺癌患者的预测性生物标志物

期刊:Molecular Cancer Research

影响因子:4.7

doi:10.1158/1541-7786.MCR-21-0383

Chai, Shoujie; Matsumoto, Nicholas; Storgard, Ryan; Peng, Chen-Ching; Aparicio, Ana; Ormseth, Benjamin; Rappard, Kate; Cunningham, Katherine; Kolatkar, Anand; Nevarez, Rafael; Tu, Kai-Han; Hsu, Ching-Ju; Malihi, Paymaneh; Corn, Paul; Zurita, Amado; Hicks, James; Kuhn, Peter; Ruiz-Velasco, Carmen

Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)

雷西那德联合别嘌醇：一项针对对标准治疗反应不足的痛风患者的随机、双盲、安慰剂对照研究（多国 CLEAR 2 研究）

期刊:Annals of the Rheumatic Diseases

影响因子:20.6

doi:10.1136/annrheumdis-2016-209213

Bardin, Thomas; Keenan, Robert T; Khanna, Puja P; Kopicko, Jeff; Fung, Maple; Bhakta, Nihar; Adler, Scott; Storgard, Chris; Baumgartner, Scott; So, Alexander

Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

选择性尿酸重吸收抑制剂雷西那德联合非布司他治疗痛风石患者：一项 III 期临床试验的结果

期刊:Arthritis & Rheumatology

影响因子:10.9

doi:10.1002/art.40159

Dalbeth, Nicola; Jones, Graeme; Terkeltaub, Robert; Khanna, Dinesh; Kopicko, Jeff; Bhakta, Nihar; Adler, Scott; Fung, Maple; Storgard, Chris; Baumgartner, Scott; Perez-Ruiz, Fernando

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol

雷西纳德联合别嘌醇治疗对别嘌醇疗效不佳的痛风患者：一项 II 期随机双盲研究的结果

期刊:Annals of the Rheumatic Diseases

影响因子:20.6

doi:10.1136/annrheumdis-2015-207919

Perez-Ruiz, Fernando; Sundy, John S; Miner, Jeffrey N; Cravets, Matthew; Storgard, Chris

Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis

德国、英国、美国和法国参与临床试验的已确诊痛风患者的合并症负担：一项回顾性分析

期刊:Advances in Therapy

影响因子:4

doi:10.1007/s12325-016-0346-1

Nyberg, Fredrik; Horne, Laura; Morlock, Robert; Nuevo, Javier; Storgard, Chris; Aiyer, Lalitha; Hines, Dionne M; Ansolabehere, Xavier; Chevalier, Pierre

Nelfinavir is effective against human cervical cancer cells in vivo: a potential treatment modality in resource-limited settings

奈非那韦在体内对人类宫颈癌细胞有效：一种资源有限环境下的潜在治疗方式

期刊:Drug Design Development and Therapy

影响因子:3.5

doi:10.2147/DDDT.S102241

Mitzie-Ann Davis, Joe R Delaney, Chandni B Patel, Ryan Storgard, Dwayne G Stupack

Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis

美国、英国、德国和法国痛风患者的疾病控制、卫生资源利用、医疗保健成本和预测因素：一项回顾性分析

期刊:Rheumatology and Therapy

影响因子:2.9

doi:10.1007/s40744-016-0033-3

Morlock, Robert; Chevalier, Pierre; Horne, Laura; Nuevo, Javier; Storgard, Chris; Aiyer, Lalitha; Hines, Dionne M; Ansolabehere, Xavier; Nyberg, Fredrik

Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males

雷西纳德（一种选择性尿酸重吸收抑制剂）在健康成年男性中的药代动力学、药效学和安全性

期刊:Drug Design Development and Therapy

影响因子:5.1

doi:10.2147/DDDT.S85193

Shen, Zancong; Rowlings, Colin; Kerr, Brad; Hingorani, Vijay; Manhard, Kimberly; Quart, Barry; Yeh, Li-Tain; Storgard, Chris

发表日期：2015

文献求助收藏

T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

嵌合抗原受体T细胞疗法后的T细胞恶性肿瘤

Dermatologic Adverse Events Associated With Chimeric Antigen Receptor T-Cell Therapy: A Pharmacovigilance Analysis of the FDA Reporting System

嵌合抗原受体T细胞疗法相关皮肤不良事件：FDA报告系统的药物警戒分析

Platelet-Coated Circulating Tumor Cells Are a Predictive Biomarker in Patients with Metastatic Castrate-Resistant Prostate Cancer

血小板包被的循环肿瘤细胞是转移性去势抵抗性前列腺癌患者的预测性生物标志物

Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)

雷西那德联合别嘌醇：一项针对对标准治疗反应不足的痛风患者的随机、双盲、安慰剂对照研究（多国 CLEAR 2 研究）

Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

选择性尿酸重吸收抑制剂雷西那德联合非布司他治疗痛风石患者：一项 III 期临床试验的结果

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol

雷西纳德联合别嘌醇治疗对别嘌醇疗效不佳的痛风患者：一项 II 期随机双盲研究的结果

Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis

德国、英国、美国和法国参与临床试验的已确诊痛风患者的合并症负担：一项回顾性分析

Nelfinavir is effective against human cervical cancer cells in vivo: a potential treatment modality in resource-limited settings

奈非那韦在体内对人类宫颈癌细胞有效：一种资源有限环境下的潜在治疗方式

Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis

美国、英国、德国和法国痛风患者的疾病控制、卫生资源利用、医疗保健成本和预测因素：一项回顾性分析

Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males

雷西纳德（一种选择性尿酸重吸收抑制剂）在健康成年男性中的药代动力学、药效学和安全性